Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Accepts healthy volunteers Results available

COVID-19 Study Assessing the Efficacy and Safety of Anti-Spike SARS CoV-2 Monoclonal Antibodies for Prevention of SARS CoV-2 Infection Asymptomatic in Healthy Adults and Adolescents Who Are Household Contacts to an Individual With a Positive SARS-CoV-2 RT-PCR Assay

ClinicalTrials.gov ID: NCT04452318

Public ClinicalTrials.gov record NCT04452318. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 1, 2026, 2:18 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Assessing the Efficacy and Safety of Anti-Spike SARS-CoV-2 Monoclonal Antibodies in Preventing SARS-CoV-2 Infection in Household Contacts of Individuals Infected With SARS-CoV-2

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Primary Objectives: Cohort A: • To evaluate the efficacy of REGN10933+REGN10987 compared to placebo in preventing symptomatic SARS-CoV-2 infection (broad-term) confirmed by RT-qPCR Cohort A and Cohort A1: • To evaluate the safety and tolerability of REGN10933+REGN10987 following subcutaneous (SC) administration compared to placebo Cohort B • To evaluate the efficacy of REGN10933+REGN10987 compared to placebo in preventing COVID-19 symptoms (broad-term) Cohort B and Cohort B1 • To evaluate the safety and tolerability of REGN10933+REGN10987 following SC administration compared to placebo

Study identification

NCT ID
NCT04452318
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Regeneron Pharmaceuticals
Industry
Enrollment
3,303 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
1 Day and older
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 12, 2020
Primary completion
Oct 3, 2021
Completion
Oct 3, 2021
Last update posted
May 14, 2023

2020 – 2021

United States locations

U.S. sites
132
U.S. states
29
U.S. cities
97
Facility City State ZIP Site status
Regeneron Study Site Mesa Arizona 85210
Regeneron Study Site Tucson Arizona 85712
Regeneron Study Site Tucson Arizona 85724
Regeneron Study Site La Mesa California 91942
Regeneron Study Site La Palma California 90623
Regeneron Study Site Long Beach California 90806
Regeneron Study Site Los Angeles California 90035
Regeneron Study Site Los Angeles California 90036
Regeneron Study Site Los Angeles California 90095
Regeneron Study Site Montclair California 91763
Regeneron Study Site Northridge California 91324
Regeneron Study Site Oxnard California 93030
Regeneron Study Site Sacramento California 95817
Regeneron Study Site Sacramento California 95821
Regeneron Study Site San Diego California 92108
Regeneron Study Site San Francisco California 94127
Regeneron Study Site Stanford California 94305
Regeneron Study Site Torrance California 90502
Regeneron Study Site Torrance California 90505
Regeneron Study Site Aurora Colorado 80045
Regeneron Study Site Colorado Springs Colorado 80907
Regeneron Study Site Washington D.C. District of Columbia 20005
Regeneron Study Site Boca Raton Florida 33487
Regeneron Study Site Clearwater Florida 33756
Regeneron Study Site DeLand Florida 32720
Regeneron Study Site Ft. Pierce Florida 34982
Regeneron Study Site Hialeah Florida 33010
Regeneron Study Site Jacksonville Florida 32216
Regeneron Study Site Lakeland Florida 33810
Regeneron Study Site Loxahatchee Groves Florida 33470
Regeneron Study Site Maitland Florida 32751
Regeneron Study Site Miami Florida 33012
Regeneron Study Site Miami Florida 33125
Regeneron Study Site Miami Florida 33126
Regeneron Study Site Miami Florida 33136
Regeneron Study Site Miami Florida 33144
Regeneron Study Site Miami Florida 33184
Regeneron Study Site Miami Florida 33186
Regeneron Study Site Orlando Florida 32803
Regeneron Study Site Sarasota Florida 34239
Regeneron Study Site Tampa Florida 33612
Regeneron Study Site West Palm Beach Florida 33407
Regeneron Study Site Winter Park Florida 32789
Regeneron Study Site Atlanta Georgia 30303
Regeneron Study Site Atlanta Georgia 30322
Regeneron Study Site Columbus Georgia 31904
Regeneron Study Site Decatur Georgia 30030
Regeneron Study Site Eatonton Georgia 31024
Regeneron Study Site Marietta Georgia 30060
Regeneron Study Site Sandy Springs Georgia 30328
Regeneron Study Site Chicago Illinois 60607
Regeneron Study Site 2 Chicago Illinois 60612
Regeneron Study Site 3 Chicago Illinois 60612
Regeneron Study Site Chicago Illinois 60612
Regeneron Study Site 1 Downers Grove Illinois 60515
Regeneron Study Site 2 Downers Grove Illinois 60515
Regeneron Study Site Ames Iowa 50010-3014
Regeneron Study Site Lake Charles Louisiana 70601
Regeneron Study Site Marrero Louisiana 70072
Regeneron Study Site Metairie Louisiana 70006
Regeneron Study Site New Orleans Louisiana 70112
Regeneron Study Site Baltimore Maryland 21201
Regeneron Study Site Boston Massachusetts 02111
Regeneron Study Site Boston Massachusetts 02114
Regeneron Study Site Boston Massachusetts 02115
Regeneron Study Site Boston Massachusetts 02118
Regeneron Study Site Boston Massachusetts 02215
Regeneron Study Site Detroit Michigan 48202
Regeneron Study Site Royal Oak Michigan 48073
Regeneron Study Site Minneapolis Minnesota 55455
Regeneron Study Site Gulfport Mississippi 39503
Regeneron Study Site Jackson Mississippi 39216
Regeneron Study Site Hazelwood Missouri 63042
Regeneron Study Site St Louis Missouri 63110
Regeneron Study Site Las Vegas Nevada 89104
Regeneron Study Site Las Vegas Nevada 89109
Regeneron Study Site Morristown New Jersey 07960
Regeneron Study Site Newark New Jersey 07103
Regeneron Study Site Summit New Jersey 07901
Regeneron Study Site Teaneck New Jersey 07666-4245
Regeneron Study Site Buffalo New York 14203
Regeneron Study Site New York New York 10016
Regeneron Study Site New York New York 10027
Regeneron Study Site New York New York 10029
Regeneron Study Site New York New York 10032
Regeneron Study Site New York New York 10037
Regeneron Study Site New York New York 10065
Regeneron Study Site 1 The Bronx New York 10451
Regeneron Study Site 2 The Bronx New York 10451
Regeneron Study Site The Bronx New York 10461
Regeneron Study Site Chapel Hill North Carolina 27599
Regeneron Study Site Charlotte North Carolina 28209
Regeneron Study Site Fayetteville North Carolina 28304
Regeneron Study Site Raleigh North Carolina 27612
Regeneron Study Site Wilmington North Carolina 28401
Regeneron Study Site Winston-Salem North Carolina 27103
Regeneron Study Site Cincinnati Ohio 45267-0405
Regeneron Study Site Columbus Ohio 43210
Regeneron Study Site Columbus Ohio 43215
Regeneron Study Site Dayton Ohio 45432
Regeneron Study Site Danville Pennsylvania 17822
Regeneron Study Site Philadelphia Pennsylvania 19104
Regeneron Study Site Philadelphia Pennsylvania 19140
Regeneron Study Site Wilkes-Barre Pennsylvania 18711
Regeneron Study Site Providence Rhode Island 02906
Regeneron Study Site Charleston South Carolina 29406
Regeneron Study Site Charleston South Carolina 29425
Regeneron Study Site Clinton South Carolina 29325
Regeneron Study Site Gaffney South Carolina 29340
Regeneron Study Site Sioux Falls South Dakota 57105
Regeneron Study Site Chattanooga Tennessee 37421
Regeneron Study Site Knoxville Tennessee 37920
Regeneron Study Site Memphis Tennessee 38103
Regeneron Study Site Nashville Tennessee 37232
Regeneron Study Site Bellaire Texas 77401
Regeneron Study Site Corpus Christi Texas 78413
Regeneron Study Site Dallas Texas 75224
Regeneron Study Site Houston Texas 77008
Regeneron Study Site Houston Texas 77024
Regeneron Study Site Houston Texas 77026
Regeneron Study Site Houston Texas 77057
Regeneron Study Site Houston Texas 77093
Regeneron Study Site Pearland Texas 77584
Regeneron Study Site Red Oak Texas 75154
Regeneron Study Site San Antonio Texas 78249
Regeneron Study Site Tyler Texas 75701
Regeneron Study Site Charlottesville Virginia 22903
Regeneron Study Site Richmond Virginia 23298
Regeneron Study Site Everett Washington 98201
Regeneron Study Site Seattle Washington 98104
Regeneron Study Site Yakima Washington 98902
Regeneron Study Site Madison Wisconsin 53792

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04452318, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 14, 2023 · Synced Sep 1, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04452318 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →